mebendazole and n-vinyl-2-pyrrolidinone

mebendazole has been researched along with n-vinyl-2-pyrrolidinone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cuesta-Bandera, C; Daniel-Mwambete, K; Ponce-Gordo, F; Torrado, JJ; Torrado, S1
Costa, H; Oliveira, G; Pedrosa, C; Praça, F; Romariz, J1
Bansal, AK; Chawla, G; Kumar, S1
Backx, K; Boeykens, P; Bone, S; Brewster, ME; Ceulemans, J; Hillewaert, V; Jager, C; Kesselaers, E; Lachau-Durand, S; Mackie, C; Meurs, G; Novoa de Armas, H; Psathas, P; Smulders, S; Van Geel, K; Van Hove, B; Van Speybroeck, M; Verheyen, L; Verreck, G; Vialpando, M; Vodak, D; Voets, M; Weuts, I1
Balogh, A; Boeykens, P; Borbás, E; Démuth, B; Galata, DL; Mackie, C; Marosi, G; Nagy, ZK; Pataki, H; Psathas, P; Van Assche, I; Van Hove, B; Verreck, G; Vialpando, M; Vigh, T1
De Beer, T; Di Pretoro, G; Portier, C; Vanhoorne, V; Vervaet, C; Vigh, T1

Other Studies

6 other study(ies) available for mebendazole and n-vinyl-2-pyrrolidinone

ArticleYear
The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
    International journal of pharmaceutics, 2004, Mar-19, Volume: 272, Issue:1-2

    Topics: Adjuvants, Pharmaceutic; Administration, Oral; Albendazole; Animals; Anthelmintics; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Linear Models; Mebendazole; Mice; Povidone; Solubility; Time Factors

2004
Anaphylaxis to povidone in a child.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2005, Volume: 16, Issue:4

    Topics: Anaphylaxis; Anti-Infective Agents, Local; Antinematodal Agents; Child; Conjunctivitis, Allergic; Dermatitis, Atopic; Eosinophilia; Humans; Immunoglobulin E; Male; Mebendazole; Pharmaceutic Aids; Povidone; Povidone-Iodine; Skin Tests

2005
Role of additives like polymers and surfactants in the crystallization of mebendazole.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:2

    Topics: Crystallization; Mebendazole; Polymers; Povidone; Sodium Dodecyl Sulfate; Solutions; Surface-Active Agents; Water

2008
Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.
    Journal of pharmaceutical sciences, 2016, Volume: 105, Issue:9

    Topics: Animals; Antinematodal Agents; Desiccation; Drug Compounding; Drug Delivery Systems; Humidity; Male; Mebendazole; Methylcellulose; Mouth Mucosa; Povidone; Rats; Rats, Sprague-Dawley; Suspensions; Vitamin E

2016
Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms.
    Drug development and industrial pharmacy, 2017, Volume: 43, Issue:7

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Chemistry, Pharmaceutical; Crystallization; Mebendazole; Nanofibers; Povidone; Rats; Tablets

2017
Continuous twin screw granulation: Impact of binder addition method and surfactants on granulation of a high-dosed, poorly soluble API.
    International journal of pharmaceutics, 2020, Mar-15, Volume: 577

    Topics: Excipients; Hypromellose Derivatives; Mebendazole; Povidone; Solubility; Surface-Active Agents; Technology, Pharmaceutical

2020